Clin2
NCT07858448Possibly a fitNot yet recruiting

Heart safety of atomoxetine in children with ADHD

Attention Deficit Hyperactivity Disorder

Part of Mental health clinical trials.

This study checks whether atomoxetine, a medicine for ADHD, affects the heart health of children. It aims to make sure the treatment is safe for kids who are just starting it.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
82 people
Ages
3 years to 16 years
Study type
Observational

Who can take part

  • Your child must be between 3 and 16 years old.
  • Your child must have a diagnosis of ADHD based on standard criteria.
  • Your child has not taken atomoxetine before.
  • Your child must be planning to start atomoxetine treatment.
  • Your child must not have heart problems like congenital heart disease, arrhythmias, or high blood pressure.
  • Your child must not be taking other medicines that affect heart rate or the heart's rhythm.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07655843Not yet recruiting
Heart health in children with ADHD on medication

This study looks at the hearts of children and teens with ADHD who have been taking medication for at least six months. It compares them with healthy children to see if there are any differences in heart function. This information may help doctors understand how ADHD medications affect the heart.

NCT07771595Not yet recruiting· Phase 4
How atomoxetine affects motivation in healthy adults

This study tests whether a medication called atomoxetine (commonly used for ADHD) can affect motivation in healthy adults. It involves taking the medication and completing tasks to measure motivation, which could help understand how this drug works.

Oxford
NCT06841666Not yet recruiting· Early Phase 1
Help for bedwetting in children with ADHD

This study tests whether a medication called atomoxetine, which is already used for ADHD, can also help reduce bedwetting at night in children with ADHD. It aims to provide a new treatment option for children who have not improved with other approaches.

NCT04216186Recruiting· Phase 3
Coenzyme Q for children with ADHD

This trial tests whether taking coenzyme Q can improve symptoms of attention-deficit/hyperactivity disorder (ADHD) in children. It may help if your child has ADHD, but it excludes certain other conditions.

Tanta
NCT05159687Recruiting· Phase 3
Atomoxetine to help prevent fainting from vasovagal episodes

This Phase 3 study tests whether atomoxetine can reduce how often vasovagal fainting happens. It may help people who have frequent fainting episodes with triggers like stress or standing for long periods.

Calgary, Alberta
NCT06870006Recruiting
Heart monitoring for kids starting psychiatric drugs

This study is for children and teens in a hospital psychiatric ward who are starting a new medicine that might affect their heart's rhythm. It will check your heart with an ECG (electrocardiogram) to make sure it stays safe.

Troina, Enna

Hear when a new ADHD trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.